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ttp://dx.doi.org/10.1016/j.ajpath.2013.06.022Semaphorin-3A (Sema3a), a guidance protein secreted by podocytes, is essential for normal kidney
patterning and glomerular ﬁltration barrier development. Here, we report that podocyte-speciﬁc
Sema3a gain-of-function in adult mice leads to proteinuric glomerular disease involving the three
layers of the glomerular ﬁltration barrier. Reversibility of the glomerular phenotype upon removal of
the transgene induction provided proof-of-principle of the cause-and-effect relationship between
podocyte Sema3a excess and glomerular disease. Mechanistically, excess Sema3a induces dysregu-
lation of nephrin, matrix metalloproteinase 9, and avb3 integrin in vivo. Sema3a cell-autonomously
disrupts podocyte shape. We identiﬁed a novel direct interaction between the Sema3a signaling
receptor plexinA1 and nephrin, linking extracellular Sema3a signals to the slit-diaphragm signaling
complex. We conclude that Sema3a functions as an extracellular negative regulator of the structure
and function of the glomerular ﬁltration barrier in the adult kidney. Our ﬁndings demonstrate
a crosstalk between Sema3a and nephrin signaling pathways that is functionally relevant both in vivo
and in vitro. (Am J Pathol 2013, 183: 1156e1168; http://dx.doi.org/10.1016/j.ajpath.2013.06.022)Supported by NIH grants R01-DK64187 (A.T.), R01-DK59333 (A.T.),
and T32-DK007110 (K.R.) and a grant from the Emerald Foundation (A.T.).
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Current address of J.J.J., Department of Pathology, Mount Sinai School of
Medicine, New York, NY; of D.B.T., Department of Pathology, University
of Miami, Miami, FL.The glomerular ﬁlter is a size-selective barrier composed of
three layers: fenestrated endothelium, glomerular basement
membrane (GBM), and podocyte foot processes.1 Disruption
of any of these components of the glomerular ﬁltration barrier
causes loss of permselectivity, proteinuria, and glomerular
disease.1 Podocyte foot processes are linked by slit dia-
phragms, which are modiﬁed adherens junctions composed
of extracellular domains of nephrin molecules associated to
a multiprotein complex.2,3 Gene mutations in slit-diaphragm
proteins and their actin-associated proteins cause familial
nephrotic syndrome.4e7 The GBM is a complex of type IV
collagen (a3, a4, and a5) and laminin 521 (a5b2g1) chains,
perlecan, syndecan, entactin, and agrin. Imbalance of
collagen and laminin chain expression results in abnormali-
ties of GBM ultrastructure and proteinuria.8,9 Loss of
glomerular endothelial fenestration due to inhibition of
vascular endothelial growth factor (VEGF-A) signaling or to
excess soluble Flt-1 causes proteinuria and preeclampsia.10,11
Semaphorin-3A (Sema3a) is a secreted guidance protein
involved in axon pathﬁnding and in cardiovascular, lung,
and kidney patterning.12,13 In the normal kidney, Sema3a is
expressed in podocytes and collecting ducts.7 Loss-of-stigative Pathology.
.function studies during kidney development showed that
Sema3a inhibits endothelial cell migration into glomeruli
and limits ureteric bud branching.14,15 Sema3a gain-of-
function during development resulted in glomerular hypo-
plasia, delayed podocyte differentiation, and absent slit
diaphragms.15 Exposure of cultured podocytes to recombi-
nant Sema3a induced down-regulation of podocin and
decreased the interactions among nephrin, podocin, and
CD2AP.16 Systemic administration of Sema3a to adult mice
induced transient, reversible foot-process effacement and
proteinuria similar to that induced by protamine sulfate.17,18
We observed increased podocyte Sema3a protein and
mRNA expression in mice with diabetic nephropathy.13,19
Taken together, our previous studies suggested that excess
Sema3a might disrupt the glomerular ﬁltration barrier in the
mature kidney, particularly in the setting of diabetes.
Excess Sema3a Causes Glomerular DiseaseThe goal of the present study was to deﬁne whether excess
podocyte Sema3a per se causes glomerular disease in adult
mice, and to examine the mechanism involved. Here, we
report that induction of podocyte-speciﬁc Sema3a over-
expression in adult mice causes a proteinuric glomerular
disease involving the three layers of the glomerular ﬁltration
barrier. Mechanistically, we show that excess Sema3a
induces dysregulation of nephrin, MMP-9, and avb3 integrin
in vivo, and we identify a novel interaction between the
Sema3a signaling receptor plexinA1 and nephrin that links
Sema3a signals to the slit-diaphragm signaling complex.
Collectively, these ﬁndings establish that Sema3a functions
as an extracellular negative regulator of the integrity and
function of the glomerular ﬁltration barrier.
Materials and Methods
Animal protocols and procedures were approved by the
institutional animal care and use committees at Albert Ein-
stein College of Medicine and Yale University School of
Medicine. Mice were housed in a pathogen-free environ-
ment. Mice were anesthetized with ketamineexylazine (0.1
mg/kg body weight i.p.), and kidneys were removed before
euthanasia. Blood and urine were obtained by cardiac and
bladder puncture, respectively.
Sema3a-Overexpressing Mice
Generation of doxycycline-regulated podocin-rtTA:tet-
O-Sema3a mice (hereafter referred to as Sema3aþ) was
performed as described previously.15 Six-week-old male
Sema3aþ mice were fed doxycycline chow (625 mg/kg
chow; Harlan-Teklad, Madison, WI) for 1 month (nZ 16).
Controls were age-matched uninduced Sema3aþ mice (nZ
18) fed standard chow and single-transgenic (podocin-rtTA
or tet-O-Sema3a) mice fed doxycycline chow for 1 month
(nZ 4). For reversibility experiments, Sema3aþ mice were
induced with doxycycline for 1 month and then were fed
standard chow for 2 weeks (n Z 10).
Noninvasive Blood Pressure Monitoring
Systolic and diastolic blood pressure were noninvasively
measured on nonanesthetized mice (nZ 4 per experimental
group) previously acclimated to the procedure, by determining
the tail blood volumewith a volume pressure recording sensor
and an occlusion tail-cuff (CODA system; Kent Scientiﬁc,
Torrington, CT). Mice were acclimated before blood pressure
readings were obtained (at least 15 readings per mouse).
Albuminuria and Creatinine Clearance
Equal volumes of urine were resolved by SDS-PAGE and
were stained with Coomassie Blue or immunoblotted with
antiebovine serum albumin antibody (Upstate 07-248;
1:1000; EMD Millipore, Billerica, MA). Creatinine wasThe American Journal of Pathology - ajp.amjpathol.orgmeasured in plasma and in 24-hour urine samples by high-
performance liquid chromatography.19
Histology and Immunohistochemistry
Kidneys were ﬁxed in 10% formalin and were parafﬁn
embedded or processed for cryosectioning. PAS staining was
performed and examined by light microscopy. Fluorescent
immunostaining was performed for total laminin (Sigma-
Aldrich, St. Louis, MO) and collagen IV (SouthernBiotech,
Birmingham, AL) in formalin-ﬁxed deparafﬁnized sections,
and for nephrin (Fitzgerald Industries International, Acton,
MA), podocin (Sigma-Aldrich), Sema3a (R&D Systems,
Minneapolis, MN), avb3 integrin (EMD Millipore), and
Wow-1 fragment antigen-binding region (Fab)20 in acetone-
ﬁxed cryosections, as described previously.11,15,19,21 Appro-
priate Cy2 and Cy3 ﬂuorescent-tagged donkey secondary
antibodies (Jackson ImmunoResearch Laboratories, West
Grove, PA)were used to visualize immunoreactive signals, and
confocal images were acquired (FluoView 300; Olympus,
Tokyo, Japan).Quantitation of immunoﬂuorescence signalwas
performedusing ImageJ software version 1.47 (NIH,Bethesda,
MD), as described by Yu et al22 with minor modiﬁcations. In
brief, the integrated density of immunoﬂuorescence-positive
signals was measured and normalized for the glomerular area
in 5 to 10 glomeruli per mouse (nZ 4 to 6 mice per experi-
mental group).
TEM
Kidney cortex was ﬁxed and processed for transmission
electron microscopy (TEM), and samples were examined on
a JEOL 1200EX microscope as described previously.15
High-resolution digitized images (2000 dpi) were used to
measure foot process width using NIH ImageJ software, as
described previously.21 Approximately 100 to 150 foot
processes per kidney were measured, adjacent to 50 mm
GBM per kidney (nZ 3 or 4 mice per experimental group).
qPCR
Total RNA was isolated from whole-kidney tissue using
TRIzol reagent (Life Technologies-Invitrogen,Carlsbad, CA)
according to the manufacturer’s instructions. One microgram
of isolated RNA from each animal was used to generate
cDNA, using a QuantiTect kit (Qiagen, Valencia, CA). PCR
reactions used pooled cDNA (n Z 4 or 5 mice per experi-
mental group), and ampliﬁcation was performed using an
Applied Biosystems SYBR Green master mix (Life Tech-
nologies) with a Mastercycler ep realplex2 system (Eppen-
dorf, Hauppauge, NY) . PCR primers were designed with
Primer Express software version 2.0 (Life Technologies), as
described previously,15 with the following additional primers
(forward and reverse): Lmx1b 50-CATCCTTTGAGGTC-
TCCTCCAA-30 and 50-GCCAGCTTCTTCATCTTTGCTC-
30; collagen IVa250-CCCATCTGACATCACACTTGTTG-301157
Reidy et aland 50-TGAGATTACGCCGGGTATCC-30; a2 laminin 50-
GACCTCTCTGGCCGCATTC-30 and 50-CCTCAGAGTT-
ACTGATGCTGATCTG-30; and b2 laminin 50-GGGTTCC-
AATGGTCACCATC-30 and 50-TGAAATGAAACTCAGC-
TTCCAGG-30. Reactions were performed in duplicate, and
each experiment was repeated three times. Gene expression
relative to the housekeeping gene GAPDH or ubiquitin
was determined with the 2DDCt method, as described
previously.15
Western Blot Analysis, Immunoprecipitation, GST, and
Overlay Assays
Kidneys were lysed in modiﬁed radioimmunoprecipitation
assay buffer, and pooled samples of whole-kidney lysates
were generated using equal amounts of protein from each
mouse (nZ 4 to 5 mice per experimental group).15 Proteins
were resolved on 8% to 15% SDS-PAGE gels, and immu-
noblotting was performed using standard technique with the
following primary antibodies: WT1 (sc-192; Santa Cruz
Biotechnology, Santa Cruz, CA), nephrin (20R-NP002;
Fitzgerald Industries International), podocin (P0372; Sigma-
Aldrich), CD2AP (sc-9137; Santa Cruz Biotechnology),
neuropilin-123; Sema3a (sc-28867; Santa Cruz Biotech-
nology), b1 and avb3 integrins (44-870G and MAB 1976Z;1158EMD Millipore), hMMP-9 (Chemicon AB-19016; EMD-
Millipore), tubulin (T6074; Sigma-Aldrich), and actin
(A2066; Sigma-Aldrich).
Whole kidney and immortalized podocytes were lysed
in immunoprecipitation buffer, precleared, and incubated
with puriﬁed 1 mg FLAG-tagged nephrin overnight at 4C,
and immunoprecipitated with anti-FLAG antibody (F7425;
Sigma-Aldrich), as described previously.21 Immunoprecipi-
tates were analyzed by Western blotting using anti-nephrin
(Fitzgerald Industries International), anti-plexinA1 (Cell
Signaling Technology, Danvers, MA), and anti-FLAG
(Sigma-Aldrich) antibodies. HEK cells were transiently
transfected with plexinA1eMyc and nephrineFLAG using
Lipofectamine 2000 reagent (Life Technologies), accord-
ing to the manufacturer’s protocol; cells were lysed 24
hours later in immunoprecipitation buffer. Lysates were
precleared and immunoprecipitated with nephrin24 and
plexinA1 antibodies, as described previously.
11,25 Immu-
noprecipitates were analyzed by Western blotting using
anti-nephrin (Fitzgerald Industries International) and anti-
plexinA1. Lysates from HEK cells transfected with plex-
inA1eMyc and nephrineFLAG were used as positive
controls.
Glutathione S-transferase (GST) binding assays were
performed as described previously,25 with minor modiﬁcations.Figure 1 Podocyte Sema3a gain-of-function
induces proteinuria. A: Western blotting indicates
that Sema3aþ mice overexpress kidney Sema3a
approximately twofold after doxycycline-induction
for 1 month. Smaller molecular weight bands
represent cleaved Sema3a. Quantitation is based
on at least three independent experiments. B: Dual
immunoﬂuorescence reveals Sema3a (red) and
podocin (green) expression in developing mouse
glomeruli; colocalization (yellow) indicates Sema3a
expression in podocytes. C and D: Western blotting
(C) and Coomassie Blue gel (D) indicate that excess
Sema3a induces reversible proteinuria, based on
albumin detected in urine samples corrected for
creatinine. E and F: Excess Sema3a does not alter
creatinine clearance (E) or blood pressure (F) within
1 month. Data are expressed as means SEM. White
bars, control (dox); black bars, Sema3a excess
(þdox); gray bars, reversibility (þ/dox). *P <
0.05. bwt, body weight. Original magniﬁcation,
400 (E).
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Excess Sema3a Causes Glomerular DiseaseIn brief, GSTenephrin cytoplasmic domain (GST-CD-neph-
rin) andGSTecontrol fusionproteins expressed inEscherichia
coliBL21 (Stratagene, La Jolla, CA) were puriﬁed using batch
puriﬁcation on glutathioneeSepharose 4B beads (GE Health-
care, Little Chalfont, UK). PlexinA1eFLAGwas puriﬁed from
HEK cells transiently transfected with pFlageCMVeplex-
inA1 construct
26 using anti-FLAG M2 afﬁnity gel and was
eluted by competition with 3 FLAG peptide (F4799;
Sigma-Aldrich). One microgram of puriﬁed plexinA1e
FLAG was incubated overnight with 0.25 mg GST fusion
proteins in PBS and 0.05% Triton-X, washed, eluted by
boiling in Laemmli buffer, resolved, immunoblotted with
anti-FLAG (Sigma-Aldrich) and anti-GST (sc-33613; Santa
Cruz Biotechnology) antibodies, and detected by enhanced
chemiluminescence.
Blot overlay assays were performed as described previ-
ously.25 Two to ten micrograms of GST-tagged fusion
proteins were resolved by SDS-PAGE, transferred to
nitrocellulose membranes, probed with 0.2 mg/mL puriﬁedThe American Journal of Pathology - ajp.amjpathol.orgplexinA1eFLAG, immunoblotted with anti-FLAG anti-
body, and detected by enhanced chemiluminescence.Generation of the Sema3aþ Podocyte Cell Line
The Sema3aþ mice (podocin-rtTA:tet-O-Sema3a15) were
bred with H-2Kb-tsA58 mice27 (Immortomouse; Jackson
Laboratory, Bar Harbor, ME) to generate a conditionally
immortalized podocyte cell line overexpressing Sema3a in
a doxycycline-regulated manner. Glomeruli were isolated
from triple-transgenic mice using magnetic beads under
sterile conditions,22,28,29 plated on collagen Iecoated dishes,
and cultured in RPMI 1640 medium (Life Technologies)
under permissive conditions (33C), as described previ-
ously.25 Podocyte primary cultures were propagated and
subjected to dilution cloning. Clones were selected on the
basis of podocyte-speciﬁc protein expression, morphology,
and doxycycline-regulated Sema3a expression and then wereFigure 2 Podocyte Sema3a gain-of-function
induces mesangial expansion foot process efface-
ment and endothelial injury. A and B: PAS staining
reveals normal glomeruli in kidneys of single-
transgenic mice with doxycycline (þdox) and in
uninduced Sema3aþ mice (dox). C and D: Two
representative Sema3a-overexpressing glomeruli
(þdox) exhibit mesangial expansion. EeH: TEM
reveals normal glomerular ﬁltration barrier
ultrastructure in uninduced Sema3aþ kidneys
(E and G). Sema3a overexpression induces foot
process effacement, endothelial cell swelling, and
marked GBM expansion (F and H). Original
magniﬁcation, 400 (AeD). Scale bars: 1 mm
(E and F) and 500 nm (G and H).
1159
Figure 3 Sema3a-induced glomerular ultrastructural abnormalities are reversible. A and D: TEM reveals normal glomerular ﬁltration barrier ultrastructure in
uninduced Sema3aþ kidneys. B and E: Sema3a podocyte overexpression induces foot process effacement, mesangial matrix expansion, and GBM lamination.
C and F: At 2 weeks after doxycycline removal (þ/dox), the Sema3a-induced foot process effacement, GBM, and endothelial cell abnormalities resolve.
G: Morphometry conﬁrms reversibility of foot process effacement. Data are expressed as means SEM. *P< 0.05. Scale bars: 1 mm (AeC); 200 nm (D); 500 nm (E
and F).
Reidy et alpropagated and induced to differentiate at 37C for at least 7
days before experiments.
Differentiated Sema3aþ podocytes plated on collagen
Iecoated glass slide chambers were kept in standard medium
or were exposed to 50 to 500 ng/mL recombinant mouse
Sema3a16 for 1 to 12 hours, ﬁxed in 4% paraformaldehyde,
and stained with rhodamine phalloidin. Images were acquired
using a Zeiss Axiovert microscope (Carl Zeiss Microscopy,
Jena, Germany) equipped with an ApoTome imaging system.
Podocyte area (mm2) was measured using Zeiss AxioVisionFigure 4 Sema3a gain-of-function disrupts GBM composition. A: IHC reveals
induced dysregulation of individual collagen IV and laminin chain mRNA, normalize
induced reversible MMP-9 up-regulation; MMP-2 remains unchanged. Quantitation
expressed as means  SEM. *P < 0.05. col, collagen. Scale bar Z 400 mm (A).
1160software version 4.8 freehand area selection on images
acquired at 600 magniﬁcation (n Z 43  8 cells per
experimental condition in four independent experiments).
Data are expressed as means  SEM.
Statistical Analysis
Student’s unpaired t-test or analysis of variance followed by
Bonferroni correction was used to compare groups, as
appropriate. P < 0.05 was deemed statistically signiﬁcant.similar distribution of collagen IV and laminin. B: qPCR indicates Sema3a-
d for control mRNA expression levels. C: Western blotting indicates Sema3a-
of fold change is based on at least four independent experiments. Data are
ajp.amjpathol.org - The American Journal of Pathology
Figure 5 Sema3a gain-of-function down-regulates nephrin expression. A: Quantitative PCR indicates decreased nephrin mRNA and stable podocin mRNA in
Sema3a-overexpressing mice. B and C: Western blotting for nephrin (B) and podocin (C) in whole-kidney lysate indicates that excess Sema3a induces
reversible nephrin down-regulation but does not affect podocin expression. Quantitation is based on at least four independent experiments. D: Immuno-
ﬂuorescence reveals down-regulation of nephrin and stable expression of podocin localized to glomerular podocytes. E: Immunoﬂuorescence reveals no change
in podocyte number (WT1þ nuclei) in Sema3a-overexpressing mice versus controls. DAPI labels nuclei; merged images conﬁrm nuclear WT1 staining. F:
Quantitation of WT1þ cells per standard area. Data are expressed as means  SEM. nZ 3 mice per experimental group (approximately 20 glomeruli quantiﬁed
per mouse). Scale bars: 100 mm (D); 20 mm (E).
Excess Sema3a Causes Glomerular DiseaseResults
Podocyte Sema3a Gain-of-Function in Adult Mice
Causes Glomerular Disease
To determine whether increased podocyte Sema3a has a patho-
genic role, we used Sema3aþ podocyte-speciﬁc, inducible
Sema3a gain-of-function adult mice.15 In these mice, the
Sema3a transgene is expressed in podocytes in a doxycycline-
regulated manner15 (Figure 1, A and B). Uninduced adult Sem-
a3aþ mice are fertile and have normal life spans, normal renal
histology, and normal glomerular ultrastructure, as assessed by
TEM (Figure 2, B, E, and G). Sema3aþmice were inducedwith
doxycycline for 1 month. Uninduced Sema3aþ and single-
transgenic mice receiving doxycycline served as controls.
Podocyte Sema3a-overexpressing mice developed protein-
uria within 4 weeks (Figure 1, C and D); their creatinine
clearance and blood pressure were normal (Figure 1, E and F).
Light microscopy revealed mesangial matrix expansion and
mild hypercellularity (Figure 2, C and D), and TEM revealedThe American Journal of Pathology - ajp.amjpathol.orgmarked glomerular abnormalities in Sema3a-overexpressing
kidneys (Figure 2, F and H). Expansion of the mesangial
matrix was conﬁrmed by TEM (Supplemental Figure S1).
Glomerular endothelial cells were swollen and exhibited
interdigitation (Figure 2, F and H), indicating that podocyte
Sema3a overexpression induces endothelial cell injury.
The GBM was thickened; the lamina rara interna was
widened by lamination, electron-dense material, and
mesangial matrix interposition (Figure 2, F and H).
Signiﬁcant podocyte foot process effacement was observed
adjacent to the GBM abnormalities (Figure 2, F and H).
Morphometric analysis of TEM images indicated increased
foot process width in Sema3a-overexpressing mice, com-
pared with uninduced mice of identical genotype or single-
transgenic tet-O-Sema3a mice (737  77 nm versus 370 
13 nm or 333  50 nm, respectively) (P < 0.05). Thus,
Sema3a-overexpressing mice developed a distinct glo-
merular disease characterized by mesangial matrix and
GBMexpansion, focal foot process effacement, endothelial
injury, and proteinuria.1161
Figure 6 Sema3a signaling receptor plexinA1 interacts with nephrin. A:
Representative Western blots and quantitation indicate no signiﬁcant
changes in plexinA1 or neuropilin 1 expression in whole kidneys after
doxycycline induction. B: Immunoﬂuorescence reveals colocalization of
plexinA1 and nephrin in cultured podocytes. C: Co-immunoprecipitation
reveals association of endogenous plexinA1 and FLAG-nephrin. Lane 1,
cultured podocytes; lane 2, whole kidney. D: Reciprocal nephrin and
plexinA1 coimmunoprecipitation reveals nephrineplexinA1 interaction in
transfected HEK cells. E and F: GST binding assay (E) indicates direct
interaction of puriﬁed FLAG-plexinA1 with nephrin cytoplasmic domain
(GST-CD-nephrin, approximately 60 kDa; red arrowhead); the GST-control is
approximately 25 kDa (black arrowhead). Overlay assay (F) indicates that
plexinA1enephrin interaction is direct. Puriﬁed FLAG-plexinA1 binds
increasing amounts of GST-CD-nephrin blotted on cellulose membrane, as
detected by FLAG immunoblotting; the GST Western blot conﬁrms equal
loading. Data are representative of at least three independent experiments.
IP, immunoprecipitation; RS, rabbit serum; WB, Western blot; WCL, whole-
cell lysate. Original magniﬁcation, 400 (B).
Reidy et alSema3a-InducedGlomerular Disease Is Partially Reversible
To determine whether the effects of podocyte Sema3a gain-of-
function are reversible, Sema3aþ mice were induced for 11162month with doxycycline and examined 2 weeks after doxy-
cycline removal (þ/dox). Sema3a-induced albuminuria
resolved 2 weeks after doxycycline removal in approxi-
mately half of the mice (6 of 11 mice) (Figure 1, C and D).
Notably, TEM revealed that the Sema3a-induced foot
process effacement and the GBM and endothelial damage
(Figure 3, B and E) also resolved upon removal of transgene
induction (Figure 3, C and F), although some mesangial
matrix expansion and focal GBM changes remained
(Supplemental Figure S1). TEM morphometric analysis
conﬁrmed that foot process width returned to baseline (from
737 77 to 380 15 nm; P< 0.05) (Figure 3G). Although
Sema3a-induced abnormalities were only partially revers-
ible, these ﬁndings provide a proof-of-principle of the
cause-and-effect relationship between podocyte Sema3a
excess and glomerular disease.
Podocyte Sema3a Gain-of-Function Disrupts GBM
Composition
To further deﬁne the GBM phenotype induced by excess
Sema3a, we examined mRNA and protein expression of
GBM components in induced Sema3aþ and uninduced
(control) kidneys. Expression of total collagen IV and
laminin, as assessed by immunohistochemistry, was similar
in induced Sema3aþ and control kidneys (Figure 4A).
Collagen IV and laminin chain immunostaining revealed no
change in localization of individual chains (data not shown);
however, a2 laminin expression was decreased in Sema3a-
overexpressing kidneys, compared with controls (data not
shown). qPCR demonstrated a signiﬁcant increase in a4 and
a5 collagen IV mRNA, whereas laminin a2, a5, b1, and b2
mRNAs were decreased to less than half their control levels
(Figure 4B), suggesting that the total laminin observed with
IHC may include abnormal laminin chains. Expression
level of the LIM homeobox transcription factor 1-beta,
a major regulator of the GBM encoded by Lmx1b,
decreased signiﬁcantly in Sema3a-overexpressing kidneys,
as determined by qPCR (Figure 4B). Next, we examined
the glomerular metalloproteinases MMP-2 and MMP-9 by
immunoblotting. MMP-9 was up-regulated in Sema3a-
overexpressing kidneys and returned to baseline on
removal of the transgene induction, whereas expression of
MMP-2 did not change (Figure 4C). Taken together, these
ﬁndings suggest that the Sema3a-induced GBM phenotype
in adult kidney results from both increased MMP-9 ex-
pression and subtle changes in collagen and laminin chain
composition.
Sema3a Gain-of-Function Decreases Nephrin
Expression
To deﬁne the molecular basis of podocyte effacement in
Sema3aþ adult mice, we examined the expression of slit-
diaphragm proteins. Nephrin expression decreased to approx-
imately 50% of control levels, as demonstrated by qPCR,ajp.amjpathol.org - The American Journal of Pathology
Figure 7 Sema3a decreases avb3 integrin glomerular activity and induces podocyte contraction and shape change. A: Western blotting and quanti-
tation indicate that avb3, b3, and b1 integrin whole-kidney expression levels were not changed by Sema3a overexpression. B: Immunoﬂuorescence reveals
decrease of both glomerular total avb3 integrin and Wow-1 (active avb3 integrin) in Sema3a-overexpressing kidneys. The avb3 integrin and nephrin
partially colocalize; negative controls demonstrate no signal in the absence of the primary antibodies (total avb3 integrin, nephrin, and active avb3
integrin). C: Quantitation of active avb3-positive signals (Wow-1), normalized for glomerular area (integrated density/mm2) indicates an approximately
50% decrease in avb3 integrin activity. D: Sema3a induced cell contraction and shape change in a dose-dependent manner; two representative images from
each condition are shown (rhodamine phalloidin staining). Note decreasing F-actin staining at higher Sema3a concentration. E: Differentiated Sema3a
podocytes exposed to vehicle or 50 ng/mL recombinant mouse Sema3a for 1 hour or 12 hours exhibited signiﬁcant change in cell size. F: Quantitation after
12 hours of Sema3a exposure indicates dose-dependent decrease in cell area. G: Model for Sema3a-induced glomerular disease mechanism. Data are
expressed as means  SEM, representative of four independent experiments (approximately 50 cells per experiment). *P < 0.05. Scale barZ 100 mm (B).
Original magniﬁcation, 600 (D).
Excess Sema3a Causes Glomerular Disease
The American Journal of Pathology - ajp.amjpathol.org 1163
Reidy et alimmunoblotting, and immunohistochemistry, whereas podocin
expression level was not altered by Sema3a excess (Figure 5,
AeC), suggesting that the decreased nephrin expression was
not a result of podocyte loss. Similar podocyte numbers in
control and Sema3a-overexpressing glomeruli was conﬁrmed
by counts of WT1þ nuclei (Figure 5, D and E). On removal of
doxycycline induction, nephrin expression returned to control
levels (Figure 5B), demonstrating a cause-and-effect relation-
ship between Sema3a excess and nephrin down-regulation.
The concomitant reversibility of podocyte foot process
effacement and proteinuria independently conﬁrmed the lack of
podocyte loss and the Sema3a-induced pathogenic mechanism
(ie, nephrin loss disrupts slit-diaphragm integrity, leading to
increased glomerular ﬁltration barrier permeability).The Sema3a Signaling Receptor PlexinA1 Interacts with
Nephrin
We examined the molecular mechanisms involved in the
crosstalk between Sema3a and nephrin signaling.Neuropilin-1
and plexinA1, Sema3a binding, and signaling receptors
12,30,31
were detected in kidney lysates and cultured podocytes by
immunoblotting and immunoﬂuorescence (Figure 6, A and B,
and Supplemental Figure S2). Puriﬁed nephrineFLAG was
found to associate with endogenous plexinA1 in vivo and in
cultured mouse podocytes, as determined by co-immunopre-
cipitation (Figure 6C). Furthermore, plexinA1 co-immuno-
precipitated with nephrin in HEK cells transiently transfected
with the corresponding constructs (Figure 6D). Overlay and
GST binding assays were performed to further evaluate plex-
inA1enephrin interaction. These experiments showed that
puriﬁed plexinA1eFLAG physically associates with the
cytoplasmic domain of nephrin (GST-CD-nephrin) (Figure 6,
E and F). Taken together, these ﬁndings demonstrate a direct
plexinA1enephrin interaction.Sema3a Decreases Glomerular avb3 Integrin Activity
and Modulates Podocyte Shape
Sema3a signaling inhibits integrin activity and thereby
modulates cell adhesion and motility.12,32 We therefore
compared avb3 and b1 integrin expression and activity in
Sema3a-overexpressing and control kidneys. Although
quantitation of avb3, b1, or b3 integrin expression in
whole-kidney lysates was similar (Figure 7A), Sema3a gain-
of-function decreased glomerular avb3 integrin expression
and activity, as assessed by immunolabeling with avb3
integrin and Wow-1 antibodies, which recognize total and
activated avb3 integrin, respectively (Figure 7B). Quanti-
tation of Wow-1 signals by morphometric analysis
conﬁrmed the observation that Sema3a gain-of-function
results in an approximately 50% decrease in glomerular
active avb3 integrin (Figure 7C), suggesting that low avb3
integrin activity contributes to the observed glomerular
phenotype.1164To determine whether Sema3a inﬂuences podocyte shape
cell-autonomously, we exposed cultured mouse podocytes
to recombinant Sema3a16 and examined cell shape, size, and
actin cytoskeleton by rhodamine phalloidin staining
(Figure 7, DeF). We observed that podocyte shape changes
develop within 1 to 12 hours of Sema3a exposure.
Morphometric analysis of time- and dose-response experi-
ments demonstrated that Sema3a induces signiﬁcant podo-
cyte contraction and F-actin collapse, resulting in decreased
size and dramatic shape changes (Figure 7, DeF).Discussion
While our previous studies showed that excess Sema3a
disrupts slit-diaphragm development, the present ﬁndings
demonstrate that a tight regulation of podocyte Sema3a is
important for the maintenance of glomerular ﬁltration
barrier structure and function in the adult kidney. In the
present study, we report that podocyte Sema3a gain-of-
function in adult mice causes glomerular disease, and
Sema3a overexpression induces reversible dysregulation of
nephrin, MMP-9, and avb3 integrin, resulting in foot
process effacement, a striking GBM phenotype, mesangial
expansion, and endothelial cell injury.
An important ﬁnding of the present study is that the
glomerular disease caused by excess podocyte Sema3a in
adult mice is partially reversible. The evidence is that
Sema3a-induced foot process effacement and endothelial
injury are reversible 2 weeks after removal of the transgene
induction. Moreover, we demonstrated that down-regulation
of nephrin induced by Sema3a gain-of-function is also
reversible, and the latter results in recovery of glomerular
permselectivity. Proteinuria resolved in more than half of the
mice; persistent proteinuria in the remainder was likely due to
the observed persistent excess extracellular matrix and focal
GBM abnormalities. Taken together, these ﬁndings provide
proof-of-principle of the cause-and-effect relationship
between podocyte Sema3a excess and glomerular disease.
Consistent with these data, we had previously found that
mice overexpressing Sema3a during glomerular develop-
ment lacked slit diaphragms at birth and that their nephrin
and WT-1 expression was decreased.15 We had also found
that cultured podocytes exposed to recombinant Sema3a
had decreased association of nephrinepodocineCD2AP
and down-regulated podocin, indicating that Sema3a
dysregulates slit-diaphragm proteins16 (albeit not precisely
in the same manner as it does in vivo, likely because of cell
culture conditions).
Another key ﬁnding of the present study is that in podo-
cytes the Sema3a signaling receptor plexinA1 interacts with
nephrin in vivo and in vitro, as shown by co-immunoprecip-
itation of native plexinA1 and puriﬁed nephrin and conﬁrm-
ed using transfected cells and puriﬁed proteins. Overlay
and GST binding assays demonstrated that plexinA1e
nephrin interaction is direct. Taken together, these ﬁndingsajp.amjpathol.org - The American Journal of Pathology
Excess Sema3a Causes Glomerular Diseaseindicate that plexinA1 is a novel component of the nephrin
signaling complex. PlexinA1enephrin interaction links
Sema3a extracellular signals to the nephrin signaling pathway
and provides a mechanism for Sema3a-induced foot process
effacement. The plexinA1 extracellular domain is known to
be autoinhibitory, and the inhibition is released on Sema3a
binding to neuropilin-1.24,33 Downstream plexinA1 signaling
is complex and involves microtubule and actin cytoskeleton
regulation via integrins, CRMPs, Rho-GTPases, and protein-
methionine sulfoxide oxidase MICAL1.12,33e35 Further
studies would be required for detailed characterization of the
downstream intracellular signaling pathways mediating the
Sema3a effects on podocytes described here. Nonetheless,
consistent with previous reports documenting Sema3a-
induced growth-cone collapse in neurons,12 as well as
F-actin collapse and inhibition of motility and migration in
endothelial cells,15,36 our present ﬁndings indicate that
Sema3a causes podocyte F-actin collapse and podocyte shape
change, in a time- and concentration-dependent manner.
Sema3a-induced cell shape changes may be mediated in part
by avb3 integrin inactivation, and may also involve micro-
tubules and myosin.37,38
Sema3a gain-of-function induces a laminated GBM
phenotype similar to that of Alport or Pierson syndrome and
that of integrin knockout and Vegf-a knockdown mice,
likely through its effects on podocytes and endothelial cells,
which together secrete the GBM components.39 The
mechanisms that regulate GBM assembly are not fully
understood, and changes in GBM composition are involved
in the pathogenesis of a variety of human proteinuric kid-
ney diseases. These include classic GBM diseases such
as Alport syndrome, diabetic nephropathy, and lupus
nephritis.9,40 Interestingly, our research group and others
have reported Sema3a dysregulation in diabetic nephrop-
athy and in lupus nephritis, respectively.19,41
A proper balance of collagen chain synthesis appears to
be required for generation of the triple helix of collagen IV
and laminin chains; indeed, permeability defects in the
Alport mouse model are exacerbated by inappropriate
laminin chain synthesis in response to a3 collagen IV
deﬁcit.8 Our present ﬁndings suggest that excess Sema3a
dysregulates MMP-9, as well as various extracellular matrix
components (a2, a5, and b1 laminins) and integrin recep-
tors (a3 and avb3) in the glomerulus. Laminin a5, a major
component of the adult glomerular basement membrane
laminin 521 (a5b2g1), is required for mesangial cell
adhesion and glomerular development and is down-
regulated in diabetic nephropathy.42,43 Mutations of b2
laminin cause Pierson syndrome, a rare form of nephrotic
syndrome.44,45 Abnormal glomerular deposition of a2
laminin has been reported in Alport syndrome.46 Down-
regulation of the Lmx1b protein suggests that Sema3a
might regulate the molecular composition of the GBM,
although similar to podocyte-speciﬁc Lmx1b-knockout mice
and to patients with nailepatella syndrome, we did not
identify the decreased expression of podocin, CD2AP, or a3The American Journal of Pathology - ajp.amjpathol.orgcollagen IV that has been described in Lmx1b-null
mice.47e50
Integrin a3 facilitates podocyte attachment to the GBM
and is required during development to organize glomerular
capillary loops and GBM assembly.51,52 Deletion of podo-
cyte b1 integrin induces podocyte effacement and laminated
GBM, demonstrating a role in podocyte attachment;
glomerular endothelium remains normal.53 Deletion of the
tetraspanin CD151 (which regulates a3 integrinemediated
adhesion) induces GBM abnormalities similar to those
observed in Alport mice and similar to our present ﬁndings,
suggesting that defects in podocyte adhesion can induce
abnormalities in GBM structure.54 Sema3a inhibits endo-
thelial cell adhesion to the extracellular matrix and cell
motility via inhibition of integrin activity in vitro.32,35 In the
kidney, avb3 integrin is expressed by the glomerular
endothelium and podocytes, the target cells for Sema3a
paracrine13,36 and autocrine7,15,16 effects. Podocyte Sema3a
gain-of-function down-regulates glomerular avb3 integrin
expression and activity in vivo. However, Sema3a-induced
changes in podocyte shape, cytoskeleton, and avb3 integ-
rin did not result in podocyte loss in vivo.
Remarkably, podocyte Vegfa knockdown induces
a glomerular phenotype similar to that of Sema3a gain-of-
function, mediated at least in part by down-regulation of
glomerular avb3 integrin expression and activity.11 Vegf-
a and Sema3a compete to bind neuropilin-1, which func-
tions as a coreceptor for Vegf-a and a binding receptor for
Sema3a.12,23,36 Of note, Vegf-a and neuropilin-1 expression
are not altered in Sema3a gain-of-function mice, and
Sema3a expression is not dysregulated in mice with podo-
cyte Vegfa knockdown (data not shown). Taken together,
these ﬁndings suggest that down-regulation of avb3 integrin
expression and activity plays a key role in disrupting the
integrity and function of the glomerular ﬁltration barrier.
Notably, this occurs downstream of both Sema3a excess
(the present study) and Vegfa knockdown,11 suggesting that
these two proteins secreted by podocytes mediate opposite
signals (in the same or independent pathways) that merge to
down-regulate integrin activity in vivo (Figure 7G), as
described in cultured cells,32,36 resulting in glomerular
phenotypes similar to integrin deletion models.
We have previously shown that Sema3a expression in
the kidney is developmentally regulated and that Sema3a
loss or gain-of-function disrupts normal glomerular ﬁltra-
tion barrier development.7,15 The transcriptional and
translational regulation of Sema3a in health and disease
are poorly understood. Similarly, the regulation of Sema3a
secretion (if any) is unknown; most studies of semaphorins
have focused on the downstream signaling, developmental,
and pathological effects.12,13,56,58 Our research group
previously reported up-regulation of Sema3a protein
expression in type 1 diabetic mice,19 and we have also
observed increased Sema3a in renal biopsies from patients
with advanced diabetic nephropathy (D. Veron and A.
Tufro, unpublished data), raising the possibility that excess1165
Reidy et alSema3a may contribute to the pathogenesis of proteinuric
kidney disease, including diabetic nephropathy. Quantita-
tion of Sema3a mRNA expression in glomeruli from db/db
mice reported by our group and others showed discrepant
results (up-regulation and down-regulation, respective-
ly),13,55 whereas neuropilin-1 mRNA decreased in diabetic
mice and humans,55 providing further indication that the
complexity of glomerular Sema3a biology warrants further
study.
Accumulating evidence suggests that Sema3a negatively
regulates immune responses via Sema3a, neuropilin-1 and
plexinA4 expressed in T cells, regulatory B cells, and acti-
vated monocytes.41,56 Sema3a dysregulation was recently
reported in human systemic lupus erythematosus; serum
Sema3a was mildly decreased, whereas Sema3a was
increased in renal tubules.56,57 Further studies are needed to
elucidate whether dysregulation of Sema3a signaling in T
cells or B cells is pathogenic in systemic lupus eryth-
ematosus and whether it is mechanistically involved in
lupus nephritis. However, given the role of Sema3a as
negative regulator of immune response and angiogenesis, as
well as its osteoprotective effect, it has been suggested that
Sema3a could be used therapeutically in immune diseases,
cancer, and osteoporosis.56,58,59 Off-target effects of
Sema3a should therefore be carefully examined.
Taken together, our present ﬁndings demonstrate that
excess podocyte Sema3a causes glomerular disease in adult
mice. Thus, tight Sema3a regulation is critical for the
maintenance of the glomerular ﬁltration barrier structure and
function. Our ﬁndings suggest that, while Sema3a-induced
down-regulation of nephrin leads to podocyte effacement,
up-regulation of MMP-9 and decreased avb3 integrin
activity in the glomerulus result in disruption of the integrity
of the GBM and endothelial injury. Direct Sema3a effects
on podocyte and endothelial cell actin cytoskeleton are
likely to contribute to podocyte effacement and endothe-
liosis in vivo. PlexinA1enephrin interaction links Sema3a
signals to the nephrin signaling pathway, providing
a mechanism for Sema3a-induced foot process effacement.
Insight into precisely how plexinA1enephrin interaction
modulates nephrin turnover and podocyte cytoskeleton will
require additional studies, including identiﬁcation of the
responsible actin-binding protein. Elucidation of the
Sema3a signaling pathway downstream from plexinA1 in
podocytes may reveal novel molecular and cellular mecha-
nisms involved in the pathogenesis of proteinuric renal
disease and diabetic nephropathy, and may identify novel
therapeutic targets as well.Acknowledgments
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